1 / 5

Injecting and BBVs – NDTMS and prevalence data

Injecting and BBVs – NDTMS and prevalence data. Current prevalence data for injecting among opiate/crack users (2010/11) shows continuation of a steady decline in the number of injectors. Injecting and BBVs – NDTMS and prevalence data.

rodd
Télécharger la présentation

Injecting and BBVs – NDTMS and prevalence data

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Injecting and BBVs – NDTMS and prevalence data • Current prevalence data for injecting among opiate/crack users (2010/11) shows continuation of a steady decline in the number of injectors Injecting and BBVs – NDTMS and prevalence data

  2. Injecting and BBVs – NDTMS and prevalence data • This is reflected in a decrease in the number and proportion of current injectors entering treatment – in 2011/12 this was 18% (~12,000) Injecting and BBVs – NDTMS and prevalence data

  3. Injecting and BBVs – NDTMS and prevalence data • NDTMS does not contain data on whether an individual has hepatitis B or hepatitis C, but rather whether they have been offered and received the appropriate vaccination or testing • Performance of providers against these indicators is monitored through routine reporting (e.g. DOMES) • Also submit data for use in regular Health Protection projects (Hep C estimates; Hepatitis C in the UK Report) Injecting and BBVs – NDTMS and prevalence data

  4. Injecting and BBVs – NDTMS and prevalence data • Uptake and receipt of hepatitis B vaccinations has declined slightly over the last three years Injecting and BBVs – NDTMS and prevalence data

  5. Injecting and BBVs – NDTMS and prevalence data • Rates of acceptance and receipt of hepatitis C tests among those with an injecting history have continued to increase over the last three years, although has levelled off in the past year Injecting and BBVs – NDTMS and prevalence data

More Related